Little is known about cancer therapy-related cardiac dysfunction occuring in children treated by anticancer drugs for malignancies. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs.
Study Type
OBSERVATIONAL
Enrollment
10,000
Cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs will be identify and describe
cancer therapy-related cardiac dysfunction associated with anticancer drugs
identification and description of cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs in the World Health Organization (WHO) database of individual safety case reports (vigibase)
Time frame: from inception to the April 31, 2024
Association between cancer therapy-related cardiac dysfunction and anticancer drug exposure in the World Health Organization (WHO) database of individual safety case reports (vigibase)
Disproportionnality analyses in Vigibase (IC025 and/or ROR) perfomed on cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase)
Time frame: from inception to the April 31, 2024
Description of the malignancies for which the incriminated drugs have been prescribed
Cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase)
Time frame: from inception to the April 31, 2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.